GDC 0879 is a potent and selective inhibitor of the glutamate receptor complex, primarily designed to target NMDA receptors and mGluR5 subtypes. As an investigational pharmaceutical agent, it is studied… Read more
GDC 0879 is a potent and selective inhibitor of the glutamate receptor complex, primarily designed to target NMDA receptors and mGluR5 subtypes. As an investigational pharmaceutical agent, it is studied for its potential in treating Huntington's disease by modulating the excitotoxicity linked to neuronal degeneration. Laboratories utilize the comprehensive range of related GDC 0879 reference standards, including impurities, metabolites, and stable isotope-labelled compounds, to support rigorous analytical testing and quality control protocols. These materials are essential for accurate impurity profiling and method validation, ensuring high precision in bioanalytical quantification during preclinical and clinical research phases. By employing these high-quality standards, researchers can effectively monitor compound stability and ensure regulatory compliance throughout the drug development process.